Archive


Category: Codiak

  • PharmaShots Weekly Snapshots (November 01 – 03, 2021)

    Lonza Collaborates with Codiak to Acquire its Exosomes Manufacturing Facility in Lexington, Massachusetts (US) Published: Nov 3, 2021 | Tags: Lonza, Codiak, Acquire, Exosomes Manufacturing Facility, Lexington, Massachusetts, US Amylyx Submits NDA to the US FDA for AMX0035 to Treat Amyotrophic Lateral Sclerosis Published: Nov 3, 2021 | Tags: Amylyx, NDA, US, FDA, AMX0035, ALS […]

  • Lonza Collaborates with Codiak to Acquire its Exosomes Manufacturing Facility in Lexington, Massachusetts (US)

    Shots: Codiak to receive $65M of in-kind manufacturing services for its clinical-stage programs and hold its pipeline of therapeutic candidates along with exosome engineering and loading technologies Lonza will obtain global access and sub-licensable rights of Codiak’s high-throughput perfusion-based cGMP process for exosome manufacturing The companies established a center of excellence to develop exosome manufacturing […]